What is GETAFIX?
Although vaccination programmes for COVID-19 are now underway, it will take time to bring the infection rate under control, so it is vital that research continues to find suitable treatments. We are looking for people to take part in a clinical trial (GETAFIX) of an anti-viral tablet called favipiravir. We want to know if adding favipiravir to standard treatment can help patients recover more quickly.
The trial will compare two groups of 150 – one group will receive favipiravir in addition to any standard treatment, the other will have standard treatment only. Patients who are to receive favipiravir will take the tablet for 10 days.
Full information about the study can be found here.
Please note if you require immediate medical attention for symptoms of COVID-19 you should contact your GP, or contact NHS 24 on 111 or visit nhs24.scot.